EssilorLuxottica Société anonyme (ESLOF)
OTCMKTS · Delayed Price · Currency is USD
336.00
+1.00 (0.30%)
At close: Dec 15, 2025
ESLOF Market Cap
ESLOF has a market cap or net worth of $153.21 billion as of December 15, 2025. Its market cap has increased by 38.46% in one year.
Market Cap
153.21B
Enterprise Value
167.14B
Revenue
31.99B
Ranking
n/a
PE Ratio
54.79
Stock Price
$336.00
Market Cap Chart
Since February 11, 1992, ESLOF's market cap has increased from 474.08M to 153.21B, an increase of 32,217.73%. That is a compound annual growth rate of 18.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 153.21B | 37.82% |
| Dec 31, 2024 | 111.17B | 22.76% |
| Dec 29, 2023 | 90.56B | 14.56% |
| Dec 30, 2022 | 79.05B | -15.86% |
| Dec 31, 2021 | 93.95B | 38.01% |
| Dec 31, 2020 | 68.07B | 3.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.30M |
| Glass House Brands | 743.26M |
| Elite Pharmaceuticals | 537.17M |
| CytoDyn | 407.36M |
| Northwest Biotherapeutics | 368.73M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 298.52M |
| Nika Pharmaceuticals | 291.10M |